× Industry Reports Services Press Release Contact us About us

North America Self-Monitoring Blood Glucose Devices Market Size By Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By End-User (Hospitals, Home Settings, Diagnostic Centers & Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada), End-User Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: August 2018 | Publisher: Graphical Research Report ID: GR1021 | Delivery : PDF

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1.  Paid sources

1.4.1.2.    Unpaid sources       

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. North America self-monitoring blood glucose devices market industry 3600 synopsis, 2013 - 2024

Chapter 3. North America Self-Monitoring Blood Glucose Devices Market Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1.  Technological advancements in self-monitoring glucose devices

3.3.1.2.    Growing prevalence of diabetes

3.3.1.3.    Individual and national expenditure over diabetes treatment

3.3.1.4.  Increasing adoption of sedentary lifestyle and rising obese population prone to suffer from diabetes

3.3.2. Industry pitfalls & challenges

3.3.2.1.  High cost associated with SMBG devices

3.3.2.2.    Lack of reimbursement & stringent regulations for SMBG devices

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By end-user

3.5. Competitive landscape, 2017

3.5.1.  Strategy dashboard

3.6. Porter’s analysis

3.7. PESTEL analysis

Chapter 4.  North America Self-Monitoring Blood Glucose Devices Market, By Product

4.1. Key segment trends

4.2. Self-monitoring blood glucose meters

4.2.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.3. Continuous glucose monitors

4.3.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.4. Testing strips

4.4.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.5. Lancets

4.5.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

Chapter 5. North America Self-Monitoring Blood Glucose Devices Market, By End-user

5.1. Key segment trends

5.2. Hospitals

5.2.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

5.3. Home settings

5.3.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

5.4. Diagnostic centers and clinics

5.4.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

Chapter 6. North America Self-Monitoring Blood Glucose Devices Market, By Country

6.1. Key regional trends

6.2. North America

6.2.1.  Market estimates and forecast by country, 2013 – 2024(USD Million)

6.2.2.  Market estimates and forecast by product, 2013 – 2024(USD Million)

6.2.3.  Market estimates and forecast by end-user, 2013 – 2024(USD Million)

6.2.4.  U.S.

6.2.4.1. Market estimates and forecast by product, 2013 – 2024(USD Million)

6.2.4.2. Market estimates and forecast by end-user, 2013 – 2024(USD Million)

6.2.5.  Canada

6.2.5.1. Market estimates and forecast by product, 2013 – 2024(USD Million)

6.2.5.2. Market estimates and forecast by end-user, 2013 – 2024(USD Million)

Chapter 7. Company Profiles

7.1. Abbott Laboratories

7.1.1.  Business overview

7.1.2.  Financial data

7.1.3.  Product landscape

7.1.4.  Strategic outlook

7.2. All Medicus

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.3. Arkray

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.4. B. Braun Melsungen AG

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.5. Bayer Healthcare

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.6. Bionime Corporation

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.7. Dexcom

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.8. F. Hoffmann-La Roche

7.8.1.  Business overview

7.8.2.  Financial data

7.8.3.  Product landscape

7.8.4.  Strategic outlook

7.9. Johnson & Johnson

7.9.1.   Business overview

7.9.2.  Financial data

7.9.3.  Product landscape

7.9.4.  Strategic outlook

7.10.  LifeScan

7.10.1. Business overview

7.10.2.   Financial data

7.10.3.   Product landscape

7.10.4.   Strategic outlook

7.11.  Medtronic

7.11.1. Business overview

7.11.2.   Financial data

7.11.3.   Product landscape

7.11.4.   Strategic outlook

7.12.  Nipro Diagnostics

7.12.1. Business overview

7.12.2.   Financial data

7.12.3.   Product landscape

7.12.4.   Strategic outlook

7.13.  Nova Biomedical

7.13.1. Business overview

7.13.2.   Financial data

7.13.3.   Product landscape

7.13.4.   Strategic outlook

7.14.  Sinocare

7.14.1. Business overview

7.14.2.   Financial data

7.14.3.   Product landscape

7.14.4.   Strategic outlook

7.15.  Trividia Health

7.15.1. Business overview

7.15.2.   Financial data

7.15.3.   Product landscape

7.15.4.   Strategic outlook

 

Data Tables

TABLE 1.North America self-monitoring blood glucose devices industry 360° synopsis, 2013 – 2024     

TABLE 2.Industry impact forces

TABLE 3.Self-monitoring blood glucose meters market size, by country, 2013 – 2024 (USD Million)

TABLE 4.Continuous glucose monitors market size, by country, 2013 – 2024 (USD Million)

TABLE 5.Testing strips market size, by country, 2013 – 2024 (USD Million)

TABLE 6.Lancets market size, by country, 2013 – 2024 (USD Million)

TABLE 7.Hospitals market size, by country, 2013 – 2024 (USD Million)

TABLE 8.Home settings market size, by country, 2013 – 2024 (USD Million)

TABLE 9.Diagnostic centers and clinics market size, by country, 2013 – 2024 (USD Million)

TABLE 10.North America self-monitoring blood glucose devices market size, by country, 2013-2024 (USD Million)

TABLE 11.North America self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 12.North America self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 13.U.S. self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 14.U.S. self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

TABLE 15.Canada self-monitoring blood glucose devices market size, by product, 2013-2024, (USD Million)

TABLE 16.Canada self-monitoring blood glucose devices market size, by end-user, 2013-2024, (USD Million)

Charts & Figures

FIG. 1   Industry segmentation

FIG. 2   North America self-monitoring blood glucose devices market, 2013 - 2024 (USD Million)

FIG. 3   Growth potential analysis, by product

FIG. 4   Growth potential analysis, by end-user

FIG. 5   Strategy dashboard

FIG. 6   Porter’s analysis

FIG. 7   PESTEL analysis


 


Select License

North America Self-Monitoring Blood Glucose Devices Market 2024


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media